We’re thrilled to introduce our dynamic partnership, bringing QDOSE+, our cutting-edge dosimetry platform, to Europe. By joining forces with our esteemed collaborator, KevMed Imaging, we’re on the brink of enriching Molecular Imaging and Radiotherapy across the continent.

Our shared mission to provide top-notch precision patient care has driven us to this remarkable point. With QDOSE+, QDOSE+ provides advanced features, meticulously designed for multi-radionuclide applications and pushing the boundaries of theranostics.

The stage is set for this unveiling at the 36th Annual Congress of the European Association of Nuclear Medicine – the EANM’23. Taking place in Vienna from September 9-13, this event is a hotbed of the latest radiopharmaceutical triumphs and cutting-edge technical marvels. Join us at booth #210 to experience it firsthand.

Come meet us to delve into how QDOSE+ is reshaping the entire realm of Molecular Imaging and Radiotherapy. Our partnership with KevMed Imaging is a testament to our unwavering dedication to ingenious solutions, precision, and, above all, ensuring the best possible outcomes for patients.

As we gear up to introduce QDOSE+ to Europe, we warmly invite you to be a part of this transformative journey. Alongside KevMed Imaging, we’re ushering in a new era of dosimetry excellence that will redefine healthcare practices across Europe.